Apple’s $20 Billion Artificial Intelligence Problem
If AI replaces search, it could cost Apple billions.
The 10-for-1 Stock Split Isn’t the Only Amazing Thing About Nvidia
For starters, Nvidia’s CEO started in Taiwan, ended up at a Kentucky reform school, and had a great idea at Denny’s.
$20,000 in This Vanguard ETF Incurs a Mere $8 Annual Fee, and It Has Beaten the S&P 500 and Nasdaq Composite in 2024
During the past decade, the Vanguard Growth ETF has been the best-performing ultra-low-cost Vanguard equity ETF.
How to Build a Million-Dollar Roth IRA for Your Child Starting in 2024
Give your child a head start on building a seven-figure Roth IRA by starting now.
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It’s Up 266% Since Last Year, and Wall Street Says It’s Still a Buy Today
The cybersecurity leader is building on existing advantages using AI innovations.
Best Stock Split Buy: Nvidia, Broadcom, or Chipotle?
You might be surprised which of these stocks offers the most attractive valuation.
1 Artificial Intelligence (AI) Stock Has Created Many Millionaires and Can Continue to Climb Higher
Microsoft has operated at the forefront of nearly every technological revolution for decades and is taking an early leadership position in artificial intelligence (AI).
Tesla’s Tariff Problem Has Just Begun
Even Tesla will face tariffs in Europe.
Where Will Rivian Stock Be in 1 Year?
Rivian stock is priced at all-time lows. Is now the time to buy?
At-camera gaze can increase scores in simulated interviews
Eye-contact has a significant impact on interpersonal evaluation, and online job interviews are no exception. In addition to the quality of a resume, the direction of the interviewee’s gaze might help (or hinder) their chances of securing the job.
Rapid test of cerebrospinal fluid decreases time to diagnosis for brain tumors
A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid can decrease the time to diagnosis and eliminate the need for invasive brain biopsies for some patients. Experts in neurosurgery, cancer and pathology worked tog…